These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32600916)

  • 1. The impact of candidate influenza virus and egg-based manufacture on vaccine effectiveness: Literature review and expert consensus.
    Rajaram S; Wojcik R; Moore C; Ortiz de Lejarazu R; de Lusignan S; Montomoli E; Rossi A; Pérez-Rubio A; Trilla A; Baldo V; Jandhyala R; Kassianos G
    Vaccine; 2020 Aug; 38(38):6047-6056. PubMed ID: 32600916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of Reduction in Influenza Vaccine Effectiveness Due to Egg-Adaptation Changes-Systematic Literature Review and Expert Consensus.
    Ortiz de Lejarazu-Leonardo R; Montomoli E; Wojcik R; Christopher S; Mosnier A; Pariani E; Trilla Garcia A; Fickenscher H; Gärtner BC; Jandhyala R; Zambon M; Moore C
    Vaccines (Basel); 2021 Oct; 9(11):. PubMed ID: 34835186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains.
    Galli C; Orsi A; Pariani E; Lai PL; Guarona G; Pellegrinelli L; Ebranati E; Icardi G; Panatto D
    Expert Rev Vaccines; 2020 Jan; 19(1):115-122. PubMed ID: 31875483
    [No Abstract]   [Full Text] [Related]  

  • 4. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
    Cobey S; Gouma S; Parkhouse K; Chambers BS; Ertl HC; Schmader KE; Halpin RA; Lin X; Stockwell TB; Das SR; Landon E; Tesic V; Youngster I; Pinsky BA; Wentworth DE; Hensley SE; Grad YH
    Clin Infect Dis; 2018 Jul; 67(3):327-333. PubMed ID: 29471464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influenza vaccines: the potential benefits of cell-culture isolation and manufacturing.
    Rajaram S; Boikos C; Gelone DK; Gandhi A
    Ther Adv Vaccines Immunother; 2020; 8():2515135520908121. PubMed ID: 32128506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A virus-like particle vaccination strategy expands its tolerance to H3N2 antigenic drift by enhancing neutralizing antibodies against hemagglutinin stalk.
    Yang JR; Cheng CY; Chen CY; Lin CH; Kuo CY; Huang HY; Wu FT; Yang YC; Wu CY; Liu MT; Hsiao PW
    Antiviral Res; 2017 Apr; 140():62-75. PubMed ID: 28093338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Zost SJ; Parkhouse K; Gumina ME; Kim K; Diaz Perez S; Wilson PC; Treanor JJ; Sant AJ; Cobey S; Hensley SE
    Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12578-12583. PubMed ID: 29109276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Assessment of the Antigenic Similarity of Egg-Propagated and Cell Culture-Propagated Reference Influenza Viruses as Compared with Circulating Viruses across Influenza Seasons 2002-2003 to 2017-2018.
    Rajaram S; Suphaphiphat P; van Boxmeer J; Haag M; Leav B; Iheanacho I; Kistler K; Ortiz de Lejarazu R
    Int J Environ Res Public Health; 2020 Jul; 17(15):. PubMed ID: 32731417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010-2011 to 2014-2015.
    Skowronski DM; Chambers C; De Serres G; Sabaiduc S; Winter AL; Dickinson JA; Gubbay JB; Fonseca K; Drews SJ; Charest H; Martineau C; Krajden M; Petric M; Bastien N; Li Y; Smith DJ
    J Infect Dis; 2017 Apr; 215(7):1059-1099. PubMed ID: 28180277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine effectiveness of cell-culture relative to egg-based inactivated influenza vaccine during the 2017-18 influenza season.
    Klein NP; Fireman B; Goddard K; Zerbo O; Asher J; Zhou J; King J; Lewis N
    PLoS One; 2020; 15(2):e0229279. PubMed ID: 32101582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antigenic Drift of A/H3N2/Virus and Circulation of Influenza-Like Viruses During the 2014/2015 Influenza Season in Poland.
    Bednarska K; Hallmann-Szelińska E; Kondratiuk K; Brydak LB
    Adv Exp Med Biol; 2016; 905():33-8. PubMed ID: 26956457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
    Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
    J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated annual influenza vaccination and vaccine effectiveness: review of evidence.
    Belongia EA; Skowronski DM; McLean HQ; Chambers C; Sundaram ME; De Serres G
    Expert Rev Vaccines; 2017 Jul; 16(7):1-14. PubMed ID: 28562111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly.
    de Jong JC; Beyer WE; Palache AM; Rimmelzwaan GF; Osterhaus AD
    J Med Virol; 2000 May; 61(1):94-9. PubMed ID: 10745239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies.
    Belongia EA; Simpson MD; King JP; Sundaram ME; Kelley NS; Osterholm MT; McLean HQ
    Lancet Infect Dis; 2016 Aug; 16(8):942-51. PubMed ID: 27061888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing influenza vaccine effectiveness between cell-derived and egg-derived vaccines, 2017-2018 influenza season.
    DeMarcus L; Shoubaki L; Federinko S
    Vaccine; 2019 Jul; 37(30):4015-4021. PubMed ID: 31201055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative Effectiveness of Cell-Cultured and Egg-Based Influenza Vaccines Among Elderly Persons in the United States, 2017-2018.
    Izurieta HS; Chillarige Y; Kelman J; Wei Y; Lu Y; Xu W; Lu M; Pratt D; Chu S; Wernecke M; MaCurdy T; Forshee R
    J Infect Dis; 2019 Sep; 220(8):1255-1264. PubMed ID: 30561688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.